Adage Capital Partners’s Tempest Therapeutics TPST Stock Holding History

Adage Capital Partners’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,564	Closed	-$2.64M	–	798
2020 Q1	$2.64M	Hold	2,564	–	–	0.01%	640
2019 Q4	$3.37M	Buy	+2,564	New	+$3.62M	0.01%	639
2018 Q3	–	Sell	-438	Closed	-$1.16M	–	763
2018 Q2	$1.16M	Hold	438	–	–	﹤0.01%	706
2018 Q1	$1.04M	Hold	438	–	–	﹤0.01%	687
2017 Q4	$1.79M	Hold	438	–	–	﹤0.01%	665
2017 Q3	$1.82M	Hold	438	–	–	﹤0.01%	672
2017 Q2	$2M	Hold	438	–	–	﹤0.01%	667
2017 Q1	$2.39M	Hold	438	–	–	0.01%	656
2016 Q4	$1.96M	Sell	438 -160	-27%	-$1.99M	0.01%	651
2016 Q3	$12.5M	Sell	598 -9	-1%	-$163K	0.03%	477
2016 Q2	$9.25M	Sell	607 -8	-1%	-$183K	0.03%	531
2016 Q1	$17.1M	Sell	615 -71	-10%	-$1.5M	0.05%	400
2015 Q4	$19.6M	Sell	686 -75	-10%	-$2.47M	0.05%	378
2015 Q3	$18.9M	Sell	761 -103	-12%	-$6.94M	0.05%	388
2015 Q2	$73.1M	Hold	864	–	–	0.18%	151
2015 Q1	$87.8M	Buy	864 +384	+80%	+$51.1M	0.21%	141
2014 Q4	$62.1M	Sell	480 -33	-6%	-$2.42M	0.15%	187
2014 Q3	$24.9M	Hold	513	–	–	0.06%	343
2014 Q2	$13.8M	Buy	513 +65	+15%	+$1.53M	0.04%	470
2014 Q1	$11.7M	Buy	+448	New	+$12.7M	0.03%	485

Other funds holding TPST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Adage Capital Partners's TPST Position: Q2 2020 in Review

Adage Capital Partners sold out of Tempest Therapeutics (TPST) in Q2 2020, closing a stake of 2,564 shares — an estimated $2.64M sold.

Adage Capital Partners first reported a position in TPST in Q1 2014 and held it in 20 quarters. The position peaked at $87.8M in Q1 2015. 51 funds tracked by Wall St. Rank hold TPST as of Q2 2020.

Adage Capital Partners reported no remaining Tempest Therapeutics position as of Q2 2020 after selling out during the quarter.
Adage Capital Partners sold 2,564 Tempest Therapeutics shares in Q2 2020, an estimated $2.64M.
Adage Capital Partners first reported a position in Tempest Therapeutics in Q1 2014 and held it in 20 quarters.
Adage Capital Partners's Tempest Therapeutics position peaked at $87.8M in Q1 2015.
51 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2020.

Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.